ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Gavisconell Liquid Mint, Suspension zum Einnehmen in Flaschen - 150 ml
66997001 Reckitt Benckiser (Switzerland) AG
Gavisconell Liquid Mint, Suspension zum Einnehmen in Flaschen01.11.2018
  01.11.2018
Antacids, Other Combinations (A02AX) 
WHO-DDD 
04.01.150 ml
04.01. 
D  
No 
IPCI
PR  
k.A.PR
  
7680669970017Synthetika
  
Composition
natrii alginas 500 mg, natrii hydrogenocarbonas 267 mg, calcii carbonas 160 mg, carbomerum 974P, natrii hydroxidum ad pH, aqua purificata, menthae piperitae aetheroleum, saccharinum natricum, propylis parahydroxybenzoas 6 mg, E 218 40 mg, ad suspensionem pro 10 ml corresp. natrium 142.6 mg.
Packungsbestandteile
Suspension zum Einnehmen in Flaschen 
  
 
Active AgentDose
Calcium Carbonate160 mg
Sodium Alginate500 mg
Sodium Hydrogen Carbonate267 mg
BAG: Active AgentDose
Calcium Carbonate160 mg
Sodium Alginate500 mg
Sodium Hydrogen Carbonate267 mg
 
Inactive agents additional_information
Aromatica  
E 218 conserv.
Propylis Parahydroxybenzoas conserv.
Saccharinum Natricum  
 
Source
Data was imported : 05.01.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home